Table 1.
Intragroup comparison of clinical parameters and sclerostin levels in the test group at baseline and 3 months
| Test group | Mean±SD | T | P |
|---|---|---|---|
| GI | |||
| Baseline | 1.4333±0.67126 | 5.101 | 0.000 (HS) |
| 3rd month | 0.3667±0.49881 | ||
| BI | |||
| Baseline | 3.3333±0.48795 | 16.039 | 0.000 (HS) |
| 3rd month | 0.5333±0.63994 | ||
| PPD (in mm) | |||
| Baseline | 5.20±0.414 | 12.160 | 0.000 (HS) |
| 3rd month | 2.60±0.737 | ||
| CAL (in mm) | |||
| Baseline | 5.40±0.507 | 9.539 | 0.000 (HS) |
| 3rd month | 2.80±1.014 | ||
| SOST (in pg/ml) | |||
| Baseline | 125.80±28.21145 | 5.581 | 0.000 (HS) |
| 3rd month | 82.80±9.31358 |
P<0.05, HS. HS: Highly significant, SD: Standard deviation; CAL: Clinical attachment level; GI: Gingival index; BI: Bleeding index; PPD: Probing pocket depth; SOST: Sclerostin